Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting
| Autor: | Kaoru Matsuura, Keiichi Ishida, Yoshiharu Takahara, Yoshio Sudo |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Male
Bradycardia medicine.medical_specialty Administration Oral QT interval Drug withdrawal Postoperative Complications Internal medicine Atrial Fibrillation Heart rate medicine Humans cardiovascular diseases Coronary Artery Bypass Aged business.industry Sotalol Atrial fibrillation Middle Aged medicine.disease Cardiac surgery Anesthesia Heart failure Cardiology Female medicine.symptom Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents medicine.drug |
| Zdroj: | The Japanese Journal of Thoracic and Cardiovascular Surgery. 49:614-617 |
| ISSN: | 1863-2092 1344-4964 |
| DOI: | 10.1007/bf02916225 |
| Popis: | Objective: We assessed the efficacy of postoperatively administered oral Sotalol in preventing the occurrence of postoperative atrial fibrillation.Methods: Subjects were 80 consecutive patients undergoing coronary artery bypass grafting (CABG) randomized alternately into a Sotalol group (40 patients) administered 80 mg of oral Sotalol daily starting on the postoperative day 1 and continued for 14 days, and a control group (40 patients) matched for age and gender.Results: The incidence of postoperative atrial fibrillation (21 patients) was significantly lower in the Sotalol group (6/40 patients; 15%) than in controls (15/40; 37.5%) (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink